Drugs for treatment of uterine contractile disease, including nitric oxide synthase substrates, nitric oxide donors, or nitric oxide inhibitors

摘要

Female mammals suffering from dysmenorrhea, dysfunctional uterine bleeding, premature birth and postpartum bleeding are given a nitric oxide synthase substrate, a nitric oxide donor, or both, or optionally a prostaglandin inhibitor, a prostacyclin-doctor, progestin, oxytocin Treatment by inhibiting uterine contractility by combining one or more of the antagonists or the β-myofogroups in an amount sufficient to ameliorate their symptoms; Treatment of inadequate menstruation, and lactic induction or palpation in pregnant women is achieved by palpation of uterine contractions by administration of nitric oxide inhibitors alone or in combination with progesterone antagonists, oxytocin or oxytocin analog antagonists or prostaglandins It's about things.